232 related articles for article (PubMed ID: 10220557)
1. Single amino acid substitution of serine82 to asparagine in first intracellular loop of human cholecystokinin (CCK)-B receptor confers full cyclic AMP responses to CCK and gastrin.
Wu SV; Yang M; Avedian D; Birnbaumer M; Walsh JH
Mol Pharmacol; 1999 May; 55(5):795-803. PubMed ID: 10220557
[TBL] [Abstract][Full Text] [Related]
2. First intracellular loop of the human cholecystokinin-A receptor is essential for cyclic AMP signaling in transfected HEK-293 cells.
Wu V; Yang M; McRoberts JA; Ren J; Seensalu R; Zeng N; Dagrag M; Birnbaumer M; Walsh JH
J Biol Chem; 1997 Apr; 272(14):9037-42. PubMed ID: 9083028
[TBL] [Abstract][Full Text] [Related]
3. Identification of cholecystokinin-B/gastrin receptor domains that confer high gastrin affinity: utilization of a novel Xenopus laevis cholecystokinin receptor.
Schmitz F; Pratt DS; Wu MJ; Kolakowski LF; Beinborn M; Kopin AS
Mol Pharmacol; 1996 Aug; 50(2):436-41. PubMed ID: 8700154
[TBL] [Abstract][Full Text] [Related]
4. Arginine 197 of the cholecystokinin-A receptor binding site interacts with the sulfate of the peptide agonist cholecystokinin.
Gigoux V; Maigret B; Escrieut C; Silvente-Poirot S; Bouisson M; Fehrentz JA; Moroder L; Gully D; Martinez J; Vaysse N; Fourmy AD
Protein Sci; 1999 Nov; 8(11):2347-54. PubMed ID: 10595537
[TBL] [Abstract][Full Text] [Related]
5. CCKA and CCKB receptors are expressed in small cell lung cancer lines and mediate Ca2+ mobilization and clonal growth.
Sethi T; Herget T; Wu SV; Walsh JH; Rozengurt E
Cancer Res; 1993 Nov; 53(21):5208-13. PubMed ID: 8221657
[TBL] [Abstract][Full Text] [Related]
6. Cholecystokinin-B/gastrin receptor binding peptides: preclinical development and evaluation of their diagnostic and therapeutic potential.
Behr TM; Béhé M; Angerstein C; Gratz S; Mach R; Hagemann L; Jenner N; Stiehler M; Frank-Raue K; Raue F; Becker W
Clin Cancer Res; 1999 Oct; 5(10 Suppl):3124s-3138s. PubMed ID: 10541353
[TBL] [Abstract][Full Text] [Related]
7. Cholecystokinin-B (CCK-B)/gastrin receptor targeting peptides for staging and therapy of medullary thyroid cancer and other CCK-B receptor expressing malignancies.
Béhé M; Behr TM
Biopolymers; 2002; 66(6):399-418. PubMed ID: 12658727
[TBL] [Abstract][Full Text] [Related]
8. Functional significance of the BBXXB motif reversed present in the cytoplasmic domains of the human follicle-stimulating hormone receptor.
Timossi C; Ortiz-Elizondo C; Pineda DB; Dias JA; Conn PM; Ulloa-Aguirre A
Mol Cell Endocrinol; 2004 Aug; 223(1-2):17-26. PubMed ID: 15279907
[TBL] [Abstract][Full Text] [Related]
9. Insights into the binding and activation sites of the receptors for cholecystokinin and gastrin.
Foucaud M; Archer-Lahlou E; Marco E; Tikhonova IG; Maigret B; Escrieut C; Langer I; Fourmy D
Regul Pept; 2008 Jan; 145(1-3):17-23. PubMed ID: 17961734
[TBL] [Abstract][Full Text] [Related]
10. Further evidence for a C-terminal structural motif in CCK2 receptor active peptide hormones.
Stone SR; Giragossian C; Mierke DF; Jackson GE
Peptides; 2007 Nov; 28(11):2211-22. PubMed ID: 17950490
[TBL] [Abstract][Full Text] [Related]
11. Purification, amino acid sequence, synthesis, and receptor selectivity of alligator gastrin.
Vigna SR; Elsey RM; Cheek AO; Faull KF; Reeve JR
Gen Comp Endocrinol; 1997 Nov; 108(2):316-26. PubMed ID: 9356227
[TBL] [Abstract][Full Text] [Related]
12. Mapping of ligand binding sites of the cholecystokinin-B/gastrin receptor with lipo-gastrin peptides and molecular modeling.
Lutz J; Romano-Götsch R; Escrieut C; Fourmy D; Mathä B; Müller G; Kessler H; Moroder L
Biopolymers; 1997 Jun; 41(7):799-817. PubMed ID: 9128441
[TBL] [Abstract][Full Text] [Related]
13. Gastrin stimulates growth of human colon cancer cells via a receptor other than CCK-A or CCK-B.
Bold RJ; Ishizuka J; Townsend CM; Thompson JC
Biochem Biophys Res Commun; 1994 Aug; 202(3):1222-6. PubMed ID: 8060296
[TBL] [Abstract][Full Text] [Related]
14. Measurement of intermolecular distances for the natural agonist Peptide docked at the cholecystokinin receptor expressed in situ using fluorescence resonance energy transfer.
Harikumar KG; Pinon DI; Wessels WS; Dawson ES; Lybrand TP; Prendergast FG; Miller LJ
Mol Pharmacol; 2004 Jan; 65(1):28-35. PubMed ID: 14722234
[TBL] [Abstract][Full Text] [Related]
15. A single amino acid of the cholecystokinin-B/gastrin receptor determines specificity for non-peptide antagonists.
Beinborn M; Lee YM; McBride EW; Quinn SM; Kopin AS
Nature; 1993 Mar; 362(6418):348-50. PubMed ID: 8455720
[TBL] [Abstract][Full Text] [Related]
16. Cysteine residues are involved in structure and function of melanocortin 1 receptor: Substitution of a cysteine residue in transmembrane segment two converts an agonist to antagonist.
Frändberg PA; Doufexis M; Kapas S; Chhajlani V
Biochem Biophys Res Commun; 2001 Mar; 281(4):851-7. PubMed ID: 11237737
[TBL] [Abstract][Full Text] [Related]
17. Cholecystokinin(CCK)-A and CCK-B/gastrin receptors in human tumors.
Reubi JC; Schaer JC; Waser B
Cancer Res; 1997 Apr; 57(7):1377-86. PubMed ID: 9102227
[TBL] [Abstract][Full Text] [Related]
18. Role of Asn-16 and Ser-19 in anthopleurin B binding. Implications for the electrostatic nature of Na(V) site 3.
Seibert AL; Liu J; Hanck DA; Blumenthal KM
Biochemistry; 2004 Jun; 43(22):7082-9. PubMed ID: 15170345
[TBL] [Abstract][Full Text] [Related]
19. Key differences in molecular complexes of the cholecystokinin receptor with structurally related peptide agonist, partial agonist, and antagonist.
Arlander SJ; Dong M; Ding XQ; Pinon DI; Miller LJ
Mol Pharmacol; 2004 Sep; 66(3):545-52. PubMed ID: 15322246
[TBL] [Abstract][Full Text] [Related]
20. Binding sites and transduction process of the cholecystokininB receptor: involvement of highly conserved aromatic residues of the transmembrane domains evidenced by site-directed mutagenesis.
Jagerschmidt A; Guillaume N; Roques BP; Noble F
Mol Pharmacol; 1998 May; 53(5):878-85. PubMed ID: 9584214
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
